Skip to main content
. 2023 Apr 21;13:6. doi: 10.1038/s41387-023-00237-3

Table 3.

Associations of SSB, LNCB, and FJ intakes with FLI-defined NAFLD prevalence for categories of beverage consumption in all cohorts.

PR (95% CI)
SSB LNCB FJ
No intake ≤2 servings/week >2 servings/week No intake ≤2 servings/week >2 servings/week No intake ≤2 servings/week >2 servings/week
Lifelines
N total 13949 9262 14,122 14,476 7929 14,305 8154 11,747 17,039
N(%) cases 3325 (24) 1438 (18) 3781 (27) 2897 (20) 1454 (18) 3849 (27) 2180 (27) 2322 (20) 3698 (22)
Model 1b 1 (ref) 0.75 (0.71–0.79) 1.08 (0.99–1.09) 1 (ref) 0.95 (0.90–1.01) 1.51 (1.45–1.58) 1 (ref) 0.78 (0.75–0.82) 0.87 (0.83–0.90)
Model 2c 1 (ref) 0.77 (0.73–1.04) 0.99 (0.95–1.04) 1 (ref) 1.00 (0.95–1.06) 1.50 (1.44–1.56) 1 (ref) 0.85 (0.81–0.90) 0.94 (0.90–0.98)
Model 3d 1 (ref) 0.90 (0.86–0.95) 1.08 (1.03–1.13) 1 (ref) 1.05 (0.99–1.11) 1.48 (1.42–1.54) 1 (ref) 0.92 (0.87–0.96) 1.01 (0.97–1.06)
NQPlusa
N total 737 412 192 883 268 190 292 493 556
N(%) cases 155 (21) 90 (22) 45 (23) 160 (18) 65 (24) 65 (34) 66 (23) 109 (22) 115 (21)
Model 1b 1 (ref) 0.95 (0.76–1.20) 1.03 (0.76–1.39) 1 (ref) 1.28 (1.00–1.64) 1.78 (1.40–2.26) 1 (ref) 0.97 (0.74–1.26) 0.91 (0.70–1.18)
Model 2c 1 (ref) 0.97 (0.77–1.22) 1.01 (0.74–1.36) 1 (ref) 1.22 (0.96–1.57) 1.67 (1.30–2.13) 1 (ref) 0.99 (0.76–1.28) 0.93 (0.71–1.20)
Model 3d 1 (ref) 1.06 (0.84–1.34) 1.02 (0.74–1.39) 1 (ref) 1.17 (0.91–1.51) 1.50 (1.18–1.91) 1 (ref) 1.08 (0.83–1.41) 1.02 (0.79–1.32)
PREDIMED-Plus
N total 180 49 21 189 45 16 77 41 132
N(%) cases 139 (77) 10 (80) 17 (81) 142 (75) 40 (89) 13 (81) 58 (75) 28 (68) 109 (83)
Model 1b 1 (ref) 1.02 (0.87–1.21) 1.00 (0.79–1.26) 1 (ref) 1.20 (1.04–1.37) 1.08 (0.85–1.37) 1 (ref) 0.92 (0.72–1.18) 1.10 (0.95–1.28)
Model 2c 1 (ref) 1.00 (0.85–1.17) 0.97 (0.78–1.22) 1 (ref) 1.22 (1.07–1.40) 1.07 (0.85–1.34) 1 (ref) 0.92 (0.73–1.16) 1.10 (0.94–1.28)
Model 3d 1 (ref) 0.97 (0.83–1.14) 0.96 (0.75–1.24) 1 (ref) 1.23 (1.07–1.43) 1.12 (0.89–1.42) 1 (ref) 0.95 (0.76–1.20) 1.13 (0.96–1.32)
AOC
N total 1577 721 1195 NA NA NA 873 630 1990
N(%) cases 903 (57) 426 (59) 761 (64) 567 (65) 362 (58) 1163 (58)
Model 1b 1 (ref) 1.02 (0.94–1.10) 1.09 (1.02–1.15) NA NA NA 1 (ref) 0.89 (0.82–0.96) 0.91 (0.85–0.96)
Model 2c 1 (ref) 1.03 (0.95–1.10) 1.08 (1.02–1.15) NA NA NA 1 (ref) 0.90 (0.83–0.98) 0.94 (0.89–1.00)
Model 3d 1 (ref) 1.03 (0.96–1.11) 1.09 (1.02–1.16) NA NA NA 1 (ref) 0.92 (0.85–1.00) 0.97 (0.91–1.03)
Pooled
Model 3d 0.97 (0.89–1.05) 1.08 (1.04–1.12) 1.13 (1.00–1.26) 1.38 (1.15–1.61) 0.92 (0.88–0.97) 1.00 (0.97–1.04)
I2, p value 75%, <0.01 0%, 0.78 72%, 0.03 78%, 0.01 0%, 0.74 18%, 0.30

AOC Alpha Omega Cohort, CI confidence interval, FJ fruit juice, LNCB low/no-calorie sweetened beverages, NQPlus Nutrition Questionnaire Plus, PR prevalence ratio, SSB sugar-sweetened beverages.

aImputed with multiple imputation method.

bModel 1: adjusted for age and sex.

cModel 2: model 1 with additional adjustment for education levels, moderate physical activity, sedentary behaviour, smoking status, alcohol intake.

dModel 3: model 2 with additional adjustment for grains, potatoes, vegetable, fruit, meat and processed meat, dairy, coffee, tea, legumes, nuts, oils and fats, sugary foods, mutual adjustment for other beverages (SSB, LNCB, or FJ, except for AOC where LNCB consumption data was not available), and energy intake.